BridgeMD
New treatment option for Autism Spectrum Disorder
Official title How Simplified Language Affects Comprehension and Learning in Young Autistic Children
ClinicalTrials.gov ID: NCT05707923
What this study is testing
- What it's testing
- The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with ASD. The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with ASD (relative to full, grammatical utterances).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 4
You may be able to join if
- Existing or suspected autism spectrum disorder, confirmed through ADOS-2
- English as primary language
- 1-4 years old
You likely can't join if
- Known genetic condition (e.g., Down syndrome, fragile X)
- Cerebral palsy
- Acquired brain injury
- Uncorrected vision or hearing impairment
The study team makes the final eligibility decision.
Where it's taking place
- East Lansing, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 4 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include East Lansing, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.